AmTech, headquartered in Shenzhen, China, is an innovative high-tech enterprise found in September 2017, and focuses on R&D and manufacturing high-end IVD reagents (Enzymatic Assay, Immunoturbidimetric Assay and Chemiluminescent Immunoassay), biological raw materials and instruments for clinical and research labs.
The mission of AmTech is to become a world first class biotech enterprise driven by innovation and make significant contribution to the development of science and technology in the world. Eight state-of-the-art technology platforms have been built up. For instance, The biomacromolecule point to point covalent bioconjugation platform is the basis for developing high quality products. The tunable gene recombination platform serves as an essential tool for R&D and manufacturing biological raw materials. So far AmTech has applied for over 40 patents, and more than 20 of them have been granted.
